Assaf Gordon, MD
Interventional Pain Medicine · Arlington, VANPI 1457549156
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 375 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 52 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations.
Across 375 payments — averaging $24.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Abbott$1K
- Medtronic$825
- AbbVie$783
- Collegium Pharmaceutical, Inc.$607
- Scilex Pharmaceuticals Inc.$426
- plus $4K from 46 others
What the payments were for
- Food & beverage$9,348100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$517
- PROCLAIM$151
- INTELLIS ADAPTIVESTIM$147
- Prospera$143
- iFuse Implant$137
- TISSEEL$131
- Qutenza$130
- Trinity ELITE$111
- Alloquent S$111
- SPINAL IMPLANT$104
- LUCEMYRA$100
How this compares
$9,348 in reported general payments places this provider in the 70th percentile of 52 interventional pain medicine providers in Virginia.
See all interventional pain medicine providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 16 | $3,240 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 134 | $1,853 |
| Celecoxib | 17 | $1,185 |
| Gabapentin | 68 | $863 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 52 | $839 |
| Naloxone Hcl | 14 | $767 |
| Pregabalin | 11 | $725 |
| Ropinirole Hcl | 23 | $716 |
| Oxycodone Hcl | 65 | $619 |
| Duloxetine Hcl | 40 | $585 |
| Diclofenac Sodium | 18 | $483 |
| Morphine Sulfate ErMorphine Sulfate | 20 | $446 |
| Hydromorphone Hcl | 40 | $438 |
| Cyclobenzaprine Hcl | 24 | $254 |
| Baclofen | 11 | $241 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Arlington
- Suneetha BudampatiArlington$10K
- Talal GhazalArlington$5K
- Ketan PatelHaymarket$133K
- Che TorryNewport News$48K
- Niteesh BhararaReston$25K
- Sassan HassassianManassas$24K
- Raj SurejaNewport News$23K
- Benjamin SeemanRichmond$21K
- Alok GopalWinchester$16K
- Jacob LeeWinchester$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.